{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:28:31Z","timestamp":1792754911306,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03985-7","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T07:08:19Z","timestamp":1750316899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The CRP\u2013albumin\u2013lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system"],"prefix":"10.1038","volume":"15","author":[{"given":"Hong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ting","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"3985_CR1","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 2, 16018 (2016).","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"15","key":"3985_CR2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular carcinoma. N. Engl. J. Med. 380(15), 1450\u20131462 (2019).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"3985_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J. Hepatol. 70(4), 674\u2013683 (2019).","journal-title":"J. Hepatol."},{"issue":"6","key":"3985_CR4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay, H. et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J. Hepatol. 77(6), 1598\u20131606 (2022).","journal-title":"J. Hepatol."},{"issue":"2","key":"3985_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3350\/cmh.2022.0316","volume":"29","author":"S Choi","year":"2023","unstructured":"Choi, S. et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990\u20132019: A DALY-based analysis of the Global Burden of Disease 2019 study. Clin. Mol. Hepatol. 29(2), 433\u2013452 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"3985_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fonc.2020.00171","volume":"10","author":"P Dasgupta","year":"2020","unstructured":"Dasgupta, P. et al. Global trends in incidence rates of primary adult liver cancers: A systematic review and meta-analysis. Front. Oncol. 10, 171 (2020).","journal-title":"Front. Oncol."},{"issue":"1","key":"3985_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188314","volume":"1873","author":"D Anwanwan","year":"2020","unstructured":"Anwanwan, D., Singh, S. K., Singh, S., Saikam, V. & Singh, R. Challenges in liver cancer and possible treatment approaches. Biochim. Biophys. Acta Rev. Cancer. 1873(1), 188314 (2020).","journal-title":"Biochim. Biophys. Acta Rev. Cancer."},{"issue":"9","key":"3985_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X Li","year":"2021","unstructured":"Li, X. et al. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat. Rev. Cancer. 21(9), 541\u2013557 (2021).","journal-title":"Nat. Rev. Cancer."},{"issue":"1","key":"3985_CR9","first-page":"625","volume":"15","author":"BI Carr","year":"2018","unstructured":"Carr, B. I. et al. C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors. Clin. Pract. (Lond) 15(1), 625\u2013634 (2018).","journal-title":"Clin. Pract. (Lond)"},{"issue":"2","key":"3985_CR10","first-page":"1626","volume":"18","author":"BI Carr","year":"2021","unstructured":"Carr, B. I. et al. CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation. Clin. Pract. (Lond). 18(2), 1626\u20131632 (2021).","journal-title":"Clin. Pract. (Lond)."},{"issue":"31","key":"3985_CR11","doi-asserted-by":"publisher","first-page":"17377","DOI":"10.1021\/jacs.3c05052","volume":"145","author":"WT Dou","year":"2023","unstructured":"Dou, W. T. et al. Orthogonally engineered albumin with attenuated macrophage phagocytosis for the targeted visualization and phototherapy of liver cancer. J. Am. Chem. Soc. 145(31), 17377\u201317388 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"3985_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2023.101911","volume":"47","author":"K Furukawa","year":"2023","unstructured":"Furukawa, K. et al. Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis. Surg. Oncol. 47, 101911 (2023).","journal-title":"Surg. Oncol."},{"key":"3985_CR13","doi-asserted-by":"publisher","first-page":"1131496","DOI":"10.3389\/fimmu.2023.1131496","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang, M. et al. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study. Front. Immunol. 14, 1131496 (2023).","journal-title":"Front. Immunol."},{"issue":"9","key":"3985_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00520-023-07997-9","volume":"31","author":"XY Liu","year":"2023","unstructured":"Liu, X. Y. et al. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer. Support Care Cancer. 31(9), 533 (2023).","journal-title":"Support Care Cancer."},{"key":"3985_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2023.112191","volume":"116","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer. Nutrition 116, 112191 (2023).","journal-title":"Nutrition"},{"issue":"1","key":"3985_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.hpb.2021.06.414","volume":"24","author":"H Iida","year":"2022","unstructured":"Iida, H. et al. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma. HPB (Oxford). 24(1), 101\u2013115 (2022).","journal-title":"HPB (Oxford)."},{"key":"3985_CR17","doi-asserted-by":"publisher","first-page":"1543665","DOI":"10.3389\/fmed.2025.1543665","volume":"12","author":"SQ Lang","year":"2025","unstructured":"Lang, S. Q., Kong, J. J., Li, G. B. & Liu, J. Prognostic value of CRP-albumin-lymphocyte index in patients with intrahepatic cholangiocarcinoma after radical resection. Front. Med. (Lausanne). 12, 1543665 (2025).","journal-title":"Front. Med. (Lausanne)."},{"key":"3985_CR18","doi-asserted-by":"crossref","unstructured":"M\u00fcller, L., Hahn, F., M\u00e4hringer-Kunz, A., Stoehr, F., Gairing, S.J., Michel, M., et al. Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: Evaluation of the CALLY Index. Cancers (Basel). 13(19) (2021).","DOI":"10.3390\/cancers13195018"},{"issue":"9","key":"3985_CR19","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.21873\/anticanres.16572","volume":"43","author":"T Aoyama","year":"2023","unstructured":"Aoyama, T., Maezawa, Y., Hashimoto, I., Rino, Y. & Oshima, T. Clinical impact of nutrition and inflammation assessment tools in pancreatic cancer treatment. Anticancer Res. 43(9), 3849\u20133860 (2023).","journal-title":"Anticancer Res."},{"issue":"3","key":"3985_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ags3.12637","volume":"7","author":"M Tsunematsu","year":"2023","unstructured":"Tsunematsu, M. et al. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy. Ann. Gastroenterol. Surg. 7(3), 503\u2013511 (2023).","journal-title":"Ann. Gastroenterol. Surg."},{"issue":"3","key":"3985_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41(3), 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"issue":"5","key":"3985_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41576-022-00553-x","volume":"24","author":"Z Seferbekova","year":"2023","unstructured":"Seferbekova, Z., Lomakin, A., Yates, L. R. & Gerstung, M. Spatial biology of cancer evolution. Nat. Rev. Genet. 24(5), 295\u2013313 (2023).","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"3985_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","volume":"20","author":"JM Argil\u00e9s","year":"2023","unstructured":"Argil\u00e9s, J. M., L\u00f3pez-Soriano, F. J., Stemmler, B. & Busquets, S. Cancer-associated cachexia\u2014Understanding the tumour macroenvironment and microenvironment to improve management. Nat. Rev. Clin. Oncol. 20(4), 250\u2013264 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"3985_CR24","first-page":"906","volume":"44","author":"K Yoshimatsu","year":"2017","unstructured":"Yoshimatsu, K. et al. A prognostic factor based on inflammation, nutrition, and immune status for fStage II\/III colorectal cancer. Gan To Kagaku Ryoho 44(10), 906\u2013908 (2017).","journal-title":"Gan To Kagaku Ryoho"},{"issue":"2","key":"3985_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","volume":"77","author":"M Barsch","year":"2022","unstructured":"Barsch, M. et al. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. J. Hepatol. 77(2), 397\u2013409 (2022).","journal-title":"J. Hepatol."},{"issue":"1","key":"3985_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-019-1047-6","volume":"18","author":"C Lu","year":"2019","unstructured":"Lu, C. et al. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: Challenges and opportunities. Mol. Cancer. 18(1), 130 (2019).","journal-title":"Mol. Cancer."},{"issue":"Pt A","key":"3985_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108220","volume":"101","author":"MB Schoenberg","year":"2021","unstructured":"Schoenberg, M. B. et al. The interactions between major immune effector cells and Hepatocellular Carcinoma: A systematic review. Int. Immunopharmacol. 101(Pt A), 108220 (2021).","journal-title":"Int. Immunopharmacol."},{"issue":"7593","key":"3985_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma, C. et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature 531(7593), 253\u2013257 (2016).","journal-title":"Nature"},{"issue":"6","key":"3985_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00595-016-1433-2","volume":"47","author":"Y Iseki","year":"2017","unstructured":"Iseki, Y. et al. The impact of the preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer. Surg. Today. 47(6), 743\u2013754 (2017).","journal-title":"Surg. Today."},{"issue":"2","key":"3985_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.17998\/jlc.20.2.106","volume":"20","author":"BS Kim","year":"2020","unstructured":"Kim, B. S. Prognostic significance of preoperative controlling nutritional status score in patients who underwent hepatic resection for hepatocellular carcinoma. J. Liver Cancer. 20(2), 106\u2013112 (2020).","journal-title":"J. Liver Cancer."},{"issue":"1","key":"3985_CR31","volume":"2","author":"J Cui","year":"2023","unstructured":"Cui, J. et al. Evidence-based guideline on immunonutrition in patients with cancer. Precis. Nutr. 2(1), e00031 (2023).","journal-title":"Precis. Nutr."},{"issue":"1","key":"3985_CR32","volume":"2","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Gut microbiota and cancer-associated malnutrition. Precis. Nutr. 2(1), e00033 (2023).","journal-title":"Precis. Nutr."},{"issue":"1","key":"3985_CR33","volume":"2","author":"M Zhou","year":"2023","unstructured":"Zhou, M. et al. Variation trends of malnutrition status among malignancy inpatients in China from 2014 to 2021. Precis. Nutr. 2(1), e00028 (2023).","journal-title":"Precis. Nutr."},{"issue":"2","key":"3985_CR34","volume":"1","author":"H Xu","year":"2022","unstructured":"Xu, H. et al. Extension protocol for the Investigation on Nutrition Status and Clinical Outcome of Patients with Common Cancers in China (INSCOC) study: 2021 update. Precis. Nutr. 1(2), e00014 (2022).","journal-title":"Precis. Nutr."},{"issue":"10","key":"3985_CR35","first-page":"593","volume":"66","author":"YY Wang","year":"2003","unstructured":"Wang, Y. Y. et al. Increased serum concentrations of tumor necrosis factor-alpha are associated with disease progression and malnutrition in hepatocellular carcinoma. J. Chin. Med. Assoc. 66(10), 593\u2013598 (2003).","journal-title":"J. Chin. Med. Assoc."},{"key":"3985_CR36","doi-asserted-by":"crossref","unstructured":"Jin, W., Jiang, S., Chen, A., Chen, Y. Effect of preoperative malnutrition based on albumin and BMI on hepatocellular carcinoma surgery and prediction of risk factors of complications. J. Gastrointest. Cancer. (2024).","DOI":"10.1007\/s12029-023-01008-0"},{"issue":"12","key":"3985_CR37","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.hpb.2023.08.012","volume":"25","author":"S Omiya","year":"2023","unstructured":"Omiya, S. et al. Impact of GLIM criteria-based malnutrition diagnosis on outcomes following liver resection for hepatocellular carcinoma. HPB (Oxford). 25(12), 1555\u20131565 (2023).","journal-title":"HPB (Oxford)."},{"issue":"6","key":"3985_CR38","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1007\/s11695-021-05237-9","volume":"31","author":"YP Mendoza","year":"2021","unstructured":"Mendoza, Y. P. et al. Malnutrition and alcohol in patients presenting with severe complications of cirrhosis after laparoscopic bariatric surgery. Obes. Surg. 31(6), 2817\u20132822 (2021).","journal-title":"Obes. Surg."},{"issue":"1","key":"3985_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","volume":"10","author":"R Spinella","year":"2016","unstructured":"Spinella, R., Sawhney, R. & Jalan, R. Albumin in chronic liver disease: Structure, functions and therapeutic implications. Hepatol. Int. 10(1), 124\u2013132 (2016).","journal-title":"Hepatol. Int."},{"issue":"3","key":"3985_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/liv.15115","volume":"42","author":"X Fu","year":"2022","unstructured":"Fu, X., Yang, Y. & Zhang, D. Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma. Liver Int. 42(3), 696\u2013709 (2022).","journal-title":"Liver Int."},{"issue":"1","key":"3985_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-023-02609-0","volume":"42","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway. J. Exp. Clin. Cancer Res. 42(1), 38 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"3985_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0038-1676806","volume":"39","author":"YM Yang","year":"2019","unstructured":"Yang, Y. M., Kim, S. Y. & Seki, E. Inflammation and liver cancer: Molecular mechanisms and therapeutic targets. Semin. Liver Dis. 39(1), 26\u201342 (2019).","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"3985_CR43","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","volume":"77","author":"M Peiseler","year":"2022","unstructured":"Peiseler, M. et al. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease\u2014Novel insights into cellular communication circuits. J. Hepatol. 77(4), 1136\u20131160 (2022).","journal-title":"J. Hepatol."},{"issue":"12","key":"3985_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13512","volume":"20","author":"S Mohammed","year":"2021","unstructured":"Mohammed, S. et al. Necroptosis contributes to chronic inflammation and fibrosis in aging liver. Aging Cell 20(12), e13512 (2021).","journal-title":"Aging Cell"},{"key":"3985_CR45","doi-asserted-by":"publisher","first-page":"1002652","DOI":"10.3389\/fimmu.2022.1002652","volume":"13","author":"C Dix","year":"2022","unstructured":"Dix, C. et al. C-reactive protein, immunothrombosis and venous thromboembolism. Front. Immunol. 13, 1002652 (2022).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03985-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T08:02:15Z","timestamp":1750320135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03985-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3985"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03985-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki,      \u00a0all participating units and institutions were approved by the relevant Ethics Committee (Registration No.: ChiCTR 1800020329), and the ethics number is Medical Research Ethics Review (2013) 82.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}],"article-number":"20090"}}